These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32482293)

  • 1. Cavitary tuberculosis: the gateway of disease transmission.
    Urbanowski ME; Ordonez AA; Ruiz-Bedoya CA; Jain SK; Bishai WR
    Lancet Infect Dis; 2020 Jun; 20(6):e117-e128. PubMed ID: 32482293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9.
    Ordonez AA; Tasneen R; Pokkali S; Xu Z; Converse PJ; Klunk MH; Mollura DJ; Nuermberger EL; Jain SK
    Dis Model Mech; 2016 Jul; 9(7):779-88. PubMed ID: 27482816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for pulmonary cavitation in tuberculosis patients from China.
    Zhang L; Pang Y; Yu X; Wang Y; Lu J; Gao M; Huang H; Zhao Y
    Emerg Microbes Infect; 2016 Oct; 5(10):e110. PubMed ID: 27729644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.
    Ong CW; Elkington PT; Friedland JS
    Am J Respir Crit Care Med; 2014 Jul; 190(1):9-18. PubMed ID: 24713029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Residual cavitary changes in the lungs in tuberculosis].
    PilipchukNS ; Golanov VS
    Sov Med; 1989; (12):71-4. PubMed ID: 2631255
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complex treatment of destructive pulmonary tuberculosis].
    Shul'ga IA; Znosenko VA; Sukhorukova IS; Davydova GN; Surovtseva EIa; Shlapakova MA; Pelipas IG
    Probl Tuberk Bolezn Legk; 2003; (7):29-31. PubMed ID: 12939873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcome of pulmonary tuberculosis with single destructive cavity depending on its size].
    Smirnov GA; Ravdel' GD; Fattakhova RM; TrofimovaRI ; Valiev RSh
    Probl Tuberk; 1990; (2):26-9. PubMed ID: 2345739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
    Strydom N; Gupta SV; Fox WS; Via LE; Bang H; Lee M; Eum S; Shim T; Barry CE; Zimmerman M; Dartois V; Savic RM
    PLoS Med; 2019 Apr; 16(4):e1002773. PubMed ID: 30939136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput phenogenotyping
    Stanley S; Spaulding CN; Liu Q; Chase MR; Ha DTM; Thai PVK; Lan NH; Thu DDA; Quang NL; Brown J; Hicks ND; Wang X; Marin M; Howard NC; Vickers AJ; Karpinski WM; Chao MC; Farhat MR; Caws M; Dunstan SJ; Thuong NTT; Fortune SM
    bioRxiv; 2023 Apr; ():. PubMed ID: 37090677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive Aerosol Exposure Promotes Cavitary Tuberculosis and Enables Screening for Targeted Inhibitors of Extensive Lung Destruction.
    Urbanowski ME; Ihms EA; Bigelow K; Kübler A; Elkington PT; Bishai WR
    J Infect Dis; 2018 Jun; 218(1):53-63. PubMed ID: 29554286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis.
    Perrin FM; Woodward N; Phillips PP; McHugh TD; Nunn AJ; Lipman MC; Gillespie SH
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1596-602. PubMed ID: 21144246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of initial cavitation to predict re-treatment with pulmonary tuberculosis.
    Huang Q; Yin Y; Kuai S; Yan Y; Liu J; Zhang Y; Shan Z; Gu L; Pei H; Wang J
    Eur J Med Res; 2016 May; 21(1):20. PubMed ID: 27154410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of cavitation in pulmonary tuberculosis.
    Helke KL; Mankowski JL; Manabe YC
    Tuberculosis (Edinb); 2006 Sep; 86(5):337-48. PubMed ID: 16359922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli.
    Converse PJ; Dannenberg AM; Estep JE; Sugisaki K; Abe Y; Schofield BH; Pitt ML
    Infect Immun; 1996 Nov; 64(11):4776-87. PubMed ID: 8890239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Appearance varied, complex diagnostics. Clinical aspects of tuberculosis].
    Müller A
    Pharm Unserer Zeit; 2012 Jan; 41(1):27-34. PubMed ID: 22470916
    [No Abstract]   [Full Text] [Related]  

  • 16. Cough and the transmission of tuberculosis.
    Turner RD; Bothamley GH
    J Infect Dis; 2015 May; 211(9):1367-72. PubMed ID: 25387581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the morphological diagnosis of drug-resistant pulmonary tuberculosis].
    Ziuzia IuR; Lepekha LN; Gedymin LE; Burtseva SA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2006; (10):56-60. PubMed ID: 17139834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.
    Dartois V
    Nat Rev Microbiol; 2014 Mar; 12(3):159-67. PubMed ID: 24487820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.
    Goswami A; Chakraborty U; Mahapatra T; Mahapatra S; Mukherjee T; Das S; Das A; Dey SK; Ray S; Bhattacharya B; Pal NK
    PLoS One; 2014; 9(10):e109563. PubMed ID: 25289974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.